Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine in total knee arthroplasty
NCT06557018Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University Dezhou Hospital
- Start
- Jun 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in osteoarthritis (OA), sponsored by Qilu Hospital of Shandong University Dezhou Hospital. Started Jun 2024; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06557018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06557018.